These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8052756)

  • 81. Increased levels of serum IgA as IgA1 monomers in ankylosing spondylitis.
    Hocini H; Iscaki S; Benlahrache C; Vitalis L; Chevalier X; Larget-Piet B; Bouvet JP
    Ann Rheum Dis; 1992 Jun; 51(6):790-2. PubMed ID: 1616365
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Serum secretory immunoglobulins in ankylosing spondylitis.
    Wendling D; Didier JM; Seilles E
    Clin Rheumatol; 1996 Nov; 15(6):590-3. PubMed ID: 8973869
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Inflammatory bowel disease and ankylosing spondylitis associated with cutaneous vasculitis, glomerulonephritis, and circulating IgA immune complexes.
    Peeters AJ; van den Wall Bake AW; Daha MR; Breeveld FC
    Ann Rheum Dis; 1990 Aug; 49(8):638-40. PubMed ID: 2204314
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Elevation of serum IgA in spondyloarthropathies and IgA nephropathy and its pathogenic role.
    Montenegro V; Monteiro RC
    Curr Opin Rheumatol; 1999 Jul; 11(4):265-72. PubMed ID: 10411380
    [TBL] [Abstract][Full Text] [Related]  

  • 85. ABO blood group and secretor status in the spondyloarthropathies.
    Shinebaum R
    FEMS Microbiol Immunol; 1989 Jun; 1(6-7):389-95. PubMed ID: 2698732
    [TBL] [Abstract][Full Text] [Related]  

  • 86. IgA mesangial nephropathy: Berger's disease.
    Sinniah R
    Am J Nephrol; 1985; 5(2):73-83. PubMed ID: 3887921
    [No Abstract]   [Full Text] [Related]  

  • 87. The role of polymeric IgA in complement-mediated solubilization of IgG and IgA immune complexes.
    Schena FP; Pastore A; Montinaro V
    Am J Kidney Dis; 1988 Nov; 12(5):433-6. PubMed ID: 3055971
    [TBL] [Abstract][Full Text] [Related]  

  • 88. A three-tiered view of the role of IgA in mucosal defense.
    Mazanec MB; Nedrud JG; Kaetzel CS; Lamm ME
    Immunol Today; 1993 Sep; 14(9):430-5. PubMed ID: 8216720
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Ankylosing spondylitis, IgA, and transforming growth factors.
    Archer JR
    Ann Rheum Dis; 1995 Jul; 54(7):544-6. PubMed ID: 7668896
    [No Abstract]   [Full Text] [Related]  

  • 90. The IgA mucosal immune system.
    Lamm ME
    Am J Kidney Dis; 1988 Nov; 12(5):384-7. PubMed ID: 3055963
    [TBL] [Abstract][Full Text] [Related]  

  • 91. [The pathogenesis of primary IgA-nephropathy].
    van den Wall Bake AW; Daha MR; van Es LA
    Tijdschr Kindergeneeskd; 1990 Apr; 58(2):55-9. PubMed ID: 2190351
    [TBL] [Abstract][Full Text] [Related]  

  • 92. IgA receptors in health and disease.
    Wines BD; Hogarth PM
    Tissue Antigens; 2006 Aug; 68(2):103-14. PubMed ID: 16866880
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Disposition of IgA-containing circulating immune complexes.
    Hebert LA
    Am J Kidney Dis; 1988 Nov; 12(5):388-92. PubMed ID: 3055964
    [TBL] [Abstract][Full Text] [Related]  

  • 94. [Spondylarthropathies and the IgA system].
    Wendling D
    Rev Med Interne; 1994 Jan; 15(1):55-61. PubMed ID: 8052756
    [TBL] [Abstract][Full Text] [Related]  

  • 95.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 96.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 97.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 98.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 5.